Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction

Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F23%3A00082986" target="_blank" >RIV/65269705:_____/23:00082986 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216224:14110/23:00133064 RIV/00216208:11120/23:43925751 RIV/00064173:_____/23:43925751 RIV/00843989:_____/23:E0110371 RIV/00159816:_____/23:00079784
Výsledek na webu
<a href="https://linkinghub.elsevier.com/retrieve/pii/S095362052300184X" target="_blank" >https://linkinghub.elsevier.com/retrieve/pii/S095362052300184X</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ejim.2023.05.032" target="_blank" >10.1016/j.ejim.2023.05.032</a>

Jazyk výsledku
angličtina
Název v původním jazyce
Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction
Popis výsledku v původním jazyce
SARS-CoV-2 predisposes patients to thrombotic disease due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis. The infection was recognized as an independent risk factor for acute myocardial infarction (AMI), which is considered part of the clinical picture of the COVID-19 disease. Cardiovascular disease increases both the susceptibility to SARS-COV-2 and the risk of death in patients with COVID-19. Among those who died and were COVID PCR-positive, almost one-third (30%) suffered from ischemic heart disease.
Název v anglickém jazyce
Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction
Popis výsledku anglicky
SARS-CoV-2 predisposes patients to thrombotic disease due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis. The infection was recognized as an independent risk factor for acute myocardial infarction (AMI), which is considered part of the clinical picture of the COVID-19 disease. Cardiovascular disease increases both the susceptibility to SARS-COV-2 and the risk of death in patients with COVID-19. Among those who died and were COVID PCR-positive, almost one-third (30%) suffered from ischemic heart disease.

Projekt
<a href="/cs/project/NV19-02-00086" target="_blank" >NV19-02-00086: Duální protidestičková léčba pacientů s akutním infarktem myokardu v kardiogenním šoku - studie DAPT-SHOCK AMI</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění
2023
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Podobné výsledky(10)